The Lenovo company has revealed a new tablet, which could be the Lenovo Xiaoxin Pad Pro 2021 tablet itself, the Lenovo Pad Pro 2021 tablet will be powered by Snapdragon 870.
- The Lenovo Xiaoxin Pad Pro 2021 tablet could be launched soon.
- The Lenovo Pad Pro 2021 tablet will be powered by Snapdragon 870.
- This Lenovo tablet will have 8 GB of RAM and 128 GB of internal storage.
The Lenovo company held an event in China a few months ago, where the company talked about new devices running Windows.
Many expected the Chinese tech giant to announce a new Android tablet, but that didn’t happen. This company has now released a teaser for a tablet, which will launch as the Lenovo Xiaoxin Pad Pro 2021.
Lenovo Xiaoxin Pad Pro 2021 Specification (Expected)
Speaking of expected specifications of Xiaoxin Pad Pro 2021, according to Weibo, this Lenovo Pad Pro 2021 features 2.5K (2560 x 1600) resolution powered by Snapdragon 870, 800,000: 1 contrast ratio and 600 nits for brightness. There will be an OLED screen.
The teaser for this Lenovo Pad Pro 2021 also confirms that the Lenovo Pad Pro 2021 display features a 90Hz refresh rate, HDR 10, TerV Rheinland certified eye protection, and Dolby Vision.
The included images of the Lenovo Pad Pro 2021 tablet show that the screen of this pad includes thin bezels of equal dimensions on each side. It also reveals that this Pad Pro 2021 tablet has a metal frame, four speakers, a USB-C port as well as a microSD / SIM card slot.
The Lenovo Pad Pro 2021 tablet will have 8 GB of RAM and 128 GB of internal storage, and the Lenovo Pad Pro 2021 tablet will be out of the box based on Android 11, the ZUI 12.5.
The tablet will also support Lenovo One, which will provide multiscreen collaboration between compatible tablets and phones.
Regarding the price of the Lenovo Xiaoxin Pad Pro 2021, no information has been received on the price of the Lenovo Xiaoxin Pad Pro 2021. Regarding the launch date of the Lenovo Xiaoxin Pad Pro 2021, the launch date of the Lenovo Xiaoxin Pad Pro 2021 has not been confirmed.